PR Newswire
NORTHFIELD, Ill., Oct. 24, 2018
NORTHFIELD, Ill., Oct. 24, 2018 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported:
Third Quarter Highlights
YTD Highlights
* Adjusted net income is a non-GAAP measure which excludes Deferred Compensation income/ expense as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.
"The Company delivered record results through the first nine months. These results have been driven by record Surfactant earnings and a lower 2018 effective tax rate," said F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer. "The quarterly and year-to-date Surfactant growth reflects higher sales volume, improved product mix and lower manufacturing costs. During the third quarter the Company approved a plan to cease Surfactant production at our German plant to further reduce our fixed cost base, refocus Surfactant resources on higher margin end markets and allow for select assets to be repurposed to support future polyol growth. The Polymer business remains down versus the prior year due to continued margin challenges and the lingering effects of the 2017 MDI shortage in Europe. Global rigid polyol volumes were up 4% versus the prior year quarter. Our Specialty Product business results were up for the quarter due to the partial catch up of order timing differences encountered in the first half of the year."
Financial Summary
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
($ in thousands, except per share data) | 2018 | 2017 | % Change | 2018 | 2017 | % Change | |||||||||||||||||
Net Sales | $ | 507,997 | $ | 487,814 | 4 | % | $ | 1,527,198 | $ | 1,451,184 | 5 | % | |||||||||||
Operating Income | $ | 27,694 | $ | 30,434 | (9) | % | $ | 112,034 | $ | 115,797 | (3) | % | |||||||||||
Net Income | $ | 22,168 | $ | 21,899 | 1 | % | $ | 85,816 | $ | 81,694 | 5 | % | |||||||||||
Earnings per Diluted Share | $ | 0.95 | $ | 0.94 | 1 | % | $ | 3.68 | $ | 3.50 | 5 | % | |||||||||||
Adjusted Net Income * | $ | 25,965 | $ | 21,448 | 21 | % | $ | 90,109 | $ | 84,041 | 7 | % | |||||||||||
Adjusted Earnings per Diluted Share * | $ | 1.11 | $ | 0.92 | 21 | % | $ | 3.86 | $ | 3.60 | 7 | % | |||||||||||
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.
Summary of Third Quarter Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense as well as certain other significant and infrequent or non-recurring items.
Percentage Change in Net Sales
The 4% increase in quarterly net sales was primarily attributable to 6% sales volume growth partially offset by the negative impact of foreign currency translation.
Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 | |||||||
Volume | 6 | % | 4 | % | ||||
Selling Price | 0 | % | 0 | % | ||||
Foreign Translation | (2) | % | 1 | % | ||||
Total | 4 | % | 5 | % |
Reported Segment Results
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||||||
($ in thousands) | 2018 | 2017 | % Change | 2018 | 2017 | % Change | ||||||||||||||||||
Net Sales | ||||||||||||||||||||||||
Surfactants | $ | 346,884 | $ | 321,444 | 8 | % | $ | 1,062,708 | $ | 973,381 | 9 | % | ||||||||||||
Polymers | $ | 141,646 | $ | 147,754 | (4) | % | $ | 404,446 | $ | 415,551 | (3) | % | ||||||||||||
Specialty Products | $ | 19,467 | $ | 18,616 | 5 | % | $ | 60,044 | $ | 62,252 | (4) | % | ||||||||||||
Total Net Sales | $ | 507,997 | $ | 487,814 | 4 | % | $ | 1,527,198 | $ | 1,451,184 | 5 | % |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
($ in thousands, all amounts pre-tax) | 2018 | 2017 | % Change | 2018 | 2017 | % Change | |||||||||||||||||
Operating Income * | |||||||||||||||||||||||
Surfactants | $ | 31,201 | $ | 22,559 | 38 | % | $ | 105,670 | $ | 92,080 | 15 | % | |||||||||||
Polymers | $ | 17,431 | $ | 21,146 | (18) | % | $ | 53,783 | $ | 63,884 | (16) | % | |||||||||||
Specialty Products | $ | 2,653 | $ | 990 | 168 | % | $ | 6,543 | $ | 7,711 | (15) | % | |||||||||||
Segment Operating | $ | 51,285 | $ | 44,695 | 15 | % | $ | 165,996 | $ | 163,675 | 1 | % | |||||||||||
Corporate Expenses | $ | (23,591) | $ | (14,261) | (65) | % | $ | (53,962) | $ | (47,878) | (13) | % | |||||||||||
Consolidated Operating | $ | 27,694 | $ | 30,434 | (9) | % | $ | 112,034 | $ | 115,797 | (3) | % |
* The 2017 operating income line items have been immaterially changed from the amounts originally reported as a result of the Company's first quarter 2018 adoption of ASU No. 2017-07 Compensation-Retirement Benefits (Topic 715).
Total segment operating income increased $6.6 million, or 15%, versus the prior year quarter. Total segment operating income for the first nine months of 2018 increased $2.3 million, or 1%, versus the prior year.
Corporate Expenses
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||||||
($ in thousands) | 2018 | 2017 | % Change | 2018 | 2017 | % Change | ||||||||||||||||||
Total - Corporate Expenses | $ | 23,591 | $ | 14,261 | 65 | % | $ | 53,962 | $ | 47,878 | 13 | % | ||||||||||||
Deferred Compensation | $ | 4,222 | $ | (129) | NM | $ | 4,971 | $ | 5,263 | (6) | % | |||||||||||||
Business Restructuring Expense | $ | 1,715 | $ | 426 | 303 | % | $ | 2,346 | $ | 1,798 | 30 | % | ||||||||||||
Adjusted Corporate Expense | $ | 17,654 | $ | 13,964 | 26 | % | $ | 46,645 | $ | 40,817 | 14 | % |
* See Table III for a discussion of deferred compensation plan accounting.
Income Taxes
The effective tax rate was 18.6% for the first nine months of 2018 versus 26.2% for the first nine months of 2017. This decrease was primarily attributable to a lower U.S. statutory tax rate of 21% in the first nine months of 2018 versus 35% in the first nine months of 2017. The Company expects its full year effective tax rate to be in the range of 19% to 22%.
Shareholder Return
The Company paid $5.1 million of dividends to shareholders in the third quarter. For the first nine months of 2018 the Company has paid $15.2 million of dividends and repurchased $13.5 million of Company stock. The Company has 520,275 shares remaining under its Board of Directors' share repurchase authorization plan. With the increased cash dividend in the fourth quarter of 2018, the Company has increased its dividend on the Company's common stock for the 51st consecutive year.
Selected Balance Sheet Information
The Company's net debt level decreased $17.9 million for the quarter while the net debt ratio dropped from 4% to 2%, mainly attributable to a $17.3 million increase in cash.
($ in millions) | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | |||||||||
Net Debt | |||||||||||||
Total Debt | $ | 286.2 | $ | 286.8 | $ | 290.8 | $ | 290.8 | |||||
Cash | 274.0 | 256.7 | 244.6 | 298.9 | |||||||||
Net Debt | $ | 12.2 | $ | 30.1 | $ | 46.2 | $ | (8.1) | |||||
Equity | 777.7 | 761.2 | 774.6 | 740.1 | |||||||||
Net Debt + Equity | $ | 789.9 | $ | 791.3 | $ | 820.8 | $ | 732.0 | |||||
Net Debt / (Net Debt + Equity) | 2 | % | 4 | % | 6 | % | -1 | % |
The major working capital components were:
($ in millions) | 9/30/18 | 6/30/18 | 3/31/18 | 12/31/17 | ||||||||
Net Receivables | $ | 323.1 | $ | 312.2 | $ | 325.3 | $ | 293.5 | ||||
Inventories | 195.2 | 188.5 | 187.7 | 172.7 | ||||||||
Accounts Payable | (209.3) | (201.3) | (202.4) | (205.0) | ||||||||
$ | 309.0 | $ | 299.4 | $ | 310.6 | $ | 261.2 |
Capital spending was $19.2 million during the quarter and $62.9 million during the first nine months of 2018. This compares to $19.6 million and $57.9 million in the prior year quarter and first nine months, respectively. For the full year, capital expenditures are expected to be between $90 million and $100 million.
Outlook
"Reported net income for the first nine months of 2018 is up 5% and adjusted net income is up 7%, both reflecting record earnings. We remain optimistic that the Company will deliver full year growth," said F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer. "We believe our Surfactant business will continue to benefit from our diversification efforts into functional products, new technologies, improved internal efficiencies and expanded sales into our broad customer base globally. Although margins will continue to challenge us in our North American Polymer business we believe we will continue to benefit from the growing global market for insulation materials. We believe full year Specialty Product results should improve over 2017."
Conference Call
Stepan Company will host a conference call to discuss the third quarter results at 10:00 a.m. ET (9:00 a.m. CT) on October 24, 2018. The call can be accessed by phone and webcast. Telephone access will be available by dialing +1 (866) 394-0807, and the webcast can be accessed through the Investor Relations/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com at the Investor Relations page at approximately the same time as this press release is issued.
Corporate Profile
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.
Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com
Contact: Luis E. Rojo, (847) 446-7500
Tables follow
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.
There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to disruptions in production or accidents at manufacturing facilities, global competition, volatility of raw material and energy costs, disruptions in transportation or significant changes in transportation costs, reduced demand due to customer product reformulations or new technologies, the probability of future acquisitions and the uncertainties related to the integration of acquired businesses, maintaining and protecting intellectual property rights, international business risks, including currency exchange rate fluctuations, legal restrictions and taxes, the impact of changes in the tax code as a result of recent federal tax legislation and uncertainty as to how some of those changes may be applied, our ability to estimate and maintain appropriate levels of recorded liabilities, our debt covenants, our ability to access capital markets, downturns in certain industries and general economic downturns, global political, military, security or other instability, costs related to expansion or other capital projects, interruption or breaches of information technology systems, the costs and other effects of governmental regulation and legal and administrative proceedings and our ability to retain executive management and key personnel.
These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
Table I | |||||||||||||||
STEPAN COMPANY | |||||||||||||||
For the Three and Nine Months Ended September 30, 2018 and 2017 | |||||||||||||||
(Unaudited – in thousands, except per share data) | |||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net Sales | $ | 507,997 | $ | 487,814 | $ | 1,527,198 | $ | 1,451,184 | |||||||
Cost of Sales * | 423,872 | 412,238 | 1,264,223 | 1,193,501 | |||||||||||
Gross Profit * | 84,125 | 75,576 | 262,975 | 257,683 | |||||||||||
Operating Expenses: | |||||||||||||||
Selling * | 14,613 | 13,710 | 42,872 | 40,396 | |||||||||||
Administrative * | 21,904 | 18,480 | 59,441 | 54,141 | |||||||||||
Research, Development and Technical Services * | 13,977 | 12,655 | 41,311 | 40,288 | |||||||||||
Deferred Compensation (Income) Expense | 4,222 | (129) | 4,971 | 5,263 | |||||||||||
54,716 | 44,716 | 148,595 | 140,088 | ||||||||||||
Business Restructuring | 1,715 | 426 | 2,346 | 1,798 | |||||||||||
Operating Income * | 27,694 | 30,434 | 112,034 | 115,797 | |||||||||||
Other Income (Expense): | |||||||||||||||
Interest, Net | (2,797) | (2,763) | (8,620) | (8,618) | |||||||||||
Other, Net * | 346 | 1,641 | 1,990 | 3,526 | |||||||||||
(2,451) | (1,122) | (6,630) | (5,092) | ||||||||||||
Income Before Income Taxes | 25,243 | 29,312 | 105,404 | 110,705 | |||||||||||
Provision for Income Taxes | 3,075 | 7,459 | 19,597 | 29,044 | |||||||||||
Net Income | 22,168 | 21,853 | 85,807 | 81,661 | |||||||||||
Net Income (Income) Loss Attributable to Noncontrolling Interests | - | 46 | 9 | 33 | |||||||||||
Net Income Attributable to Stepan Company | $ | 22,168 | $ | 21,899 | $ | 85,816 | $ | 81,694 | |||||||
Net Income Per Common Share Attributable to Stepan Company | |||||||||||||||
Basic | $ | 0.96 | $ | 0.95 | $ | 3.73 | $ | 3.56 | |||||||
Diluted | $ | 0.95 | $ | 0.94 | $ | 3.68 | $ | 3.50 | |||||||
Shares Used to Compute Net Income Per Common Share Attributable to Stepan Company | |||||||||||||||
Basic | 22,986 | 22,971 | 23,036 | 22,941 | |||||||||||
Diluted | 23,288 | 23,374 | 23,324 | 23,361 | |||||||||||
* The 2017 amounts for the noted line items have been immaterially changed from the amounts originally reported as a result of the Company's first quarter 2018 adoption of ASU No. 2017-07 Compensation – Retirement Benefits (Topic 715). The changes reflect line item reclassifications only and have no impact on pre-tax income or net income.
Table II | ||||||||||||||||||||||||||||||||
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share * | ||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||||||||||||||
($ in thousands, except per | 2018 | EPS | 2017 | EPS | 2018 | EPS | 2017 | EPS | ||||||||||||||||||||||||
Net Income Reported | $ | 22,168 | $ | 0.95 | $ | 21,899 | $ | 0.94 | $ | 85,816 | $ | 3.68 | $ | 81,694 | $ | 3.50 | ||||||||||||||||
Deferred Compensation | $ | 2,610 | $ | 0.11 | $ | (771) | $ | (0.03) | $ | 2,633 | $ | 0.11 | $ | 965 | $ | 0.04 | ||||||||||||||||
Business Restructuring | 1,187 | $ | 0.05 | 320 | $ | 0.01 | 1,660 | $ | 0.07 | $ | 1,382 | $ | 0.06 | |||||||||||||||||||
Adjusted Net Income | $ | 25,965 | $ | 1.11 | $ | 21,448 | $ | 0.92 | $ | 90,109 | $ | 3.86 | $ | 84,041 | $ | 3.60 |
* All amounts in this table are presented after-tax
The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators. These measures should be considered in addition to, neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.
Reconciliation of Pre-Tax to After-Tax Adjustments | ||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended | |||||||||||||||||||||||||||||||
($ in thousands, except per | 2018 | EPS | 2017 | EPS | 2018 | EPS | 2017 | EPS | ||||||||||||||||||||||||
Pre-Tax Adjustments | ||||||||||||||||||||||||||||||||
Deferred Compensation | $ | 3,434 | $ | (1,244) | $ | 3,465 | $ | 1,557 | ||||||||||||||||||||||||
Business Restructuring | 1,715 | 426 | $ | 2,346 | $ | 1,798 | ||||||||||||||||||||||||||
Total Pre-Tax Adjustments | $ | 5,149 | $ | (818) | $ | 5,811 | $ | 3,355 | ||||||||||||||||||||||||
Cumulative Tax Effect | $ | (1,352) | $ | 367 | $ | (1,518) | $ | (1,008) | ||||||||||||||||||||||||
After-Tax Adjustments | $ | 3,797 | $ | 0.16 | $ | (451) | $ | (0.02) | $ | 4,293 | $ | 0.18 | $ | 2,347 | $ | 0.10 |
Table III | |||||||||||||||||||||||||||||
Deferred Compensation Plan | |||||||||||||||||||||||||||||
The full effect of the deferred compensation plan on quarterly pretax income was $3.4 million of expense versus $1.2 million of income in the prior year. The year to date impact was $3.5 million of expense versus $1.6 million of expense in the prior year. The accounting for the deferred compensation plan results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise. The Company also recognizes the change in value of mutual funds as investment income or loss. The quarter end market prices of Stepan Company common stock are as follows: | |||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||
12/31 | 9/30 | 6/30 | 3/31 | 12/31 | 9/30 | 6/30 | 3/31 | ||||||||||||||||||||||
Stepan Company | N/A | $ | 87.01 | $ | 78.01 | $ | 83.18 | $ | 78.97 | $ | 83.66 | $ | 87.14 | $ | 78.81 | ||||||||||||||
The deferred compensation income statement impact is summarized below:
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||
($ in thousands) | 2018 | 2017 | 2018 | 2017 | |||||||||||
Deferred Compensation | |||||||||||||||
Operating Income (Expense) | $ | (4,222) | $ | 129 | $ | (4,971) | $ | (5,263) | |||||||
Other, net – Mutual Fund Gain | 788 | 1,115 | 1,506 | 3,706 | |||||||||||
Total Pre Tax | $ | (3,434) | $ | 1,244 | $ | (3,465) | $ | (1,557) | |||||||
Total After Tax | $ | (2,610) | $ | 771 | $ | (2,633) | $ | (965) |
Table IV | |||||||||||||||||||||||||||
Effects of Foreign Currency Translation | |||||||||||||||||||||||||||
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign currency exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The table below presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and nine month periods ending September 30, 2018 as compared to 2017: | |||||||||||||||||||||||||||
($ in millions) | Three Months Ended September 30 | Increase (Decrease) | Decrease Due to Foreign Currency Translation | Nine Months Ended September 30 | Increase (Decrease) | Increase Due to Foreign Currency Translation | |||||||||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||||||||||||||
Net Sales | $ | 508.0 | $ | 487.8 | $ | 20.2 | $ | (10.7) | $ | 1,527.2 | $ | 1,451.2 | $ | 76.0 | $ | 11.4 | |||||||||||
Gross Profit | 84.1 | 75.6 | 8.5 | (1.7) | 263.0 | 257.7 | 5.3 | 0.8 | |||||||||||||||||||
Operating Income | 27.7 | 30.4 | (2.7) | (1.1) | 112.0 | 115.8 | (3.8) | 0.2 | |||||||||||||||||||
Pretax Income | 25.2 | 29.3 | (4.1) | (0.9) | 105.4 | 110.7 | (5.3) | 0.5 |
Table V | ||||||||
Stepan Company | ||||||||
Consolidated Balance Sheets | ||||||||
September 30, 2018 and December 31, 2017 | ||||||||
Sept. 30, 2018 | Dec. 31, 2017 | |||||||
ASSETS | ||||||||
Current Assets | $ | 815,032 | $ | 788,736 | ||||
Property, Plant & Equipment, Net | 598,715 | 598,443 | ||||||
Other Assets | 78,484 | 83,682 | ||||||
Total Assets | $ | 1,492,231 | $ | 1,470,861 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | $ | 326,883 | $ | 320,253 | ||||
Deferred Income Taxes | 18,798 | 10,962 | ||||||
Long-term Debt | 262,551 | 268,299 | ||||||
Other Non-current Liabilities | 105,585 | 130,433 | ||||||
Total Stepan Company Stockholders' Equity | 777,651 | 740,096 | ||||||
Noncontrolling Interest | 763 | 818 | ||||||
Total Liabilities and Stockholders' Equity | $ | 1,492,231 | $ | 1,470,861 |
View original content:http://www.prnewswire.com/news-releases/stepan-reports-third-quarter-results-and-record-nine-month-earnings-300736707.html
SOURCE Stepan Company
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member